Hypertensive iridocyclitis

British Journal of Ophthalmology

Volumn 90, Issue 7, 2006, Pages 812-813

  Kim, E C ^a   Margolis, Todd P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FOSCARNET; GANCICLOVIR; TRIAMCINOLONE ACETONIDE; VALGANCICLOVIR; VIRUS DNA;

CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; EDITORIAL; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOASSAY; IRIDOCYCLITIS; IRITIS; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETINA NECROSIS; RETINITIS; RISK FACTOR; VIRUS DETECTION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IRIDOCYCLITIS; OCULAR HYPERTENSION; VIRUS LATENCY;

EID: 33745672960     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.091876     Document Type: Editorial

References (35)

1. Gritz DC, Wong IG. Incidence and prevalence of uveitis in northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 2004;111:491-500.
2. Newsom RW, Martin TJ, Wasilauskas B. Cat-scratch disease diagnosed serologically using an enzyme immunoassay in a patient with neuroretinitis. Arch Ophthalmol 1996;114:493-4.
3. Winterkorn JM. Lyme disease: neurologic and ophthalmic manifestations. Surv Ophthalmology, 1990;35:191-204.
4. Bains HS, Jampol LM, Caughron MC, et al. Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch Ophthalmol 2003;121:205-7.
5. Avila MP, Jalkh AE, Feldman E, et al. Manifestations of Whipple's disease in the posterior segment of the eye. Arch Ophthalmol 1984;102:384-90.
6. Croppo GP, Visvesvara GS, Leitch GJ, et al. Identification of the microsporidian Encephalitozoon hellem using immunoglobulin G monoclonal antibodies. Arch Pathol Lab Med 1998;122:182-6.
7. Goldberg MA, Kazacos KR, Boyce WM, et al. Diffuse unilateral subacute neuroretinitis. Morphometric, serologic, and epidemiologic support for Baylisascaris as a causative agent. Ophthalmology 1993;100:1695-701.
8. Rathinam SR, Rathnam S, Selvaraj S, et al. Uveitis associated with an epidemic outbreak of leptospirosis. Am J Ophthalmol 1997;124:71-9.
9. Holland GN, Muccioli C, Silveira C, et al. Intraocular inflammatory reactions without local necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis. Am J Ophthalmol 1999;128:413-20.
10. Johnson MW, Greven GM, Jaffe GJ, et al. Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 1997;104:48-57.
11. Yamamoto S, Pavan-Langston D, Kinoshita S, et al. Detecting herpesvirus DNA in uveitis using the polymerase chain reaction. Br J Ophthalmol 1996;80:465-8.
12. Nishi M, Hanashiro R, Mori S, et al. Polymerase chain reaction for the detection of the varicella-zoster genome in ocular samples from patients with acute retinal necrosis. Am J Ophthalmol 1992;114:603-9.
13. Yamamoto S, Pavan-Langston D, Tada R, et al. Possible role of herpes simplex virus in the origin of Posner-Schlossman syndrome. Am J Ophthalmol 1995;119:796-8.
14. Margolis TP, Lowder CY, Holland GN, et al. Varicella-zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophmalmol 1991;112:119-31.
15. Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 2004;138:46-54.
16. De Groot-Mijnes JD, de Visser L, Rothova A, et al. Rubella virus is associated with Fuchs heterochromic iridocyclitis. Am J Ophthalmol 2006;141:212-14.
17. De Schryver I, Rozenberg F, Cassoux N, et al. Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br J Ophthalmol 2006;90:852-5.
18. Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis 1996;12(suppl 7):S701-10.
19. Kondo K, Xu J, Mocarski ES. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci USA 1996;93:11137-42.
20. Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 1998;95:3937-42.
21. Lidehall AK, Sund F, Lundberg T, et al. T cell control of primary and latent cytomegalovirus infections in healthy subjects. J Clin Immunol 2005;25:473-81.
22. Mietz H, Aisenbrey S, Ulrich Bartz-Schmidt K, et al. Ganciclovir for the treatment of anterior uveitis. Graefes Arch Clin Exp Ophthalmol 2000;238:905-9.
23. Markomichelakis NN, Canakis C, Zafirakis P, et al. Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy. Ophthalmology 2002;109:879-82.
24. Teoh SB, Thean L, Koay E. Cytomegalovirus in aetiology of Posner-Schlossman syndrome: evidence from quantitative porymerase chain reaction. Eye 2005;19:1338-40.
25. Klemola E, Von Essen R, Henle G, et al. Infectious-mononucleosis-like disease with negative heterophil agglutination lest. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J Infect Dis 1970;121:608-14.
26. Hayes K, Alford C, Britt W. Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis. J Infect Dis 1987;156:615-21.
27. Cohen JI, Corey GR. Cytomegalovirus infection in the normal host. Medicine 1985;64:100-14.
28. Klauber E, Briski LE, Khatib R. Cytomegalovirus colitis in the immunocompetent host: an overview. Scand J Infect Dis 1998;30:559-64.
29. Eddleston M, Peacock S, Juniper M, et al. Severe Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 1997;24:52-6.
30. Studahl M, Bergstrom T, Ekeland-Sjoberg K, et al. Detection of cytomegalovirus DNA in cerebrospinal fluid in immunocompetent patients as a sign of active infection. J Med Virol 1995;46:274-80.
31. Almanzar G, Schwaiger S, Jenewein B, et al. B. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 2005;79:3675-83.
32. McVoy MA, Adler SP. Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. J Infect Dis 1989;160:1-10.
33. Docke W-D, Kiessling C, Worm M, et al. Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatits. Br J Derm 2003;148:954-63.
34. Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, et al. Cytomegalovirus- specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 2005;175:8218-25.
35. Saidel MA, Berreen J, Margolis TP. Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient. Am J Ophthalmol 2005;140:1141-3.